GEODE CAPITAL MANAGEMENT, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$16,810,603
-59.5%
1,793,864
+6.1%
0.00%
-60.0%
Q2 2023$41,474,775
+16.8%
1,690,777
+10.8%
0.01%0.0%
Q1 2023$35,496,493
+95549.5%
1,525,418
+4.0%
0.01%0.0%
Q4 2022$37,111
-99.9%
1,466,278
+3.5%
0.01%
+25.0%
Q3 2022$27,304,000
-22.3%
1,416,229
+2.7%
0.00%
-20.0%
Q2 2022$35,119,000
+9.6%
1,378,869
+10.7%
0.01%
+25.0%
Q1 2022$32,031,000
-37.9%
1,245,391
+1.1%
0.00%
-33.3%
Q4 2021$51,576,000
-0.9%
1,231,820
+3.0%
0.01%
-14.3%
Q3 2021$52,039,000
-5.7%
1,195,758
+2.4%
0.01%
-12.5%
Q2 2021$55,191,000
-0.1%
1,167,340
+8.3%
0.01%0.0%
Q1 2021$55,239,000
+113.5%
1,077,422
+11.5%
0.01%
+100.0%
Q4 2020$25,879,000
-17.6%
966,375
+5.7%
0.00%
-33.3%
Q3 2020$31,388,000
+96.7%
914,310
+134.8%
0.01%
+100.0%
Q2 2020$15,954,000
+300.5%
389,423
+234.9%
0.00%
+200.0%
Q1 2020$3,984,000
+349.7%
116,280
+64.8%
0.00%
Q4 2019$886,00070,5580.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders